Form 4: Alignment Healthcare Executive Dawn Maroney Acquires Shares Through PSU Vesting, Sells to Cover Taxes

Dawn Christine Maroney, President of Alignment Healthcare, acquired 1,020,442 shares of common stock through the vesting of performance share units (PSUs) and subsequently sold 278,917 shares to cover tax obligations.

Summary

• On March 4, 2025, Dawn Christine Maroney, President of Alignment Healthcare, acquired 1,020,442 shares of common stock due to the vesting of performance share units (PSUs).
• The PSUs vested because Alignment Healthcare achieved certain performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA, less capital expenditures, above specified targets.
• 50% of the granted PSUs vested on March 4, 2025, and the remaining 50% will vest on December 31, 2025, contingent upon continued service to the company.
• On March 6, 2025, Maroney sold 278,917 shares at a weighted-average price of $15.53 to cover tax withholding obligations related to the PSU vesting.
• The sales occurred in multiple transactions with prices ranging from $15.12 to $16.065 per share.
• Following these transactions, Maroney directly owns 2,303,975 shares of Alignment Healthcare common stock.

Sentiment

Score: 7

Explanation: The document indicates positive performance by Alignment Healthcare, as evidenced by the vesting of PSUs. The subsequent sale of shares for tax purposes is a neutral event. Overall, the sentiment is moderately positive.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance targets related to revenue growth, medical benefit ratio, and adjusted EBITDA.
• Maroney's continued service is incentivized by the remaining 50% of PSUs vesting on December 31, 2025.

Negatives

• The sale of shares to cover tax obligations, while not discretionary, could be perceived negatively by some investors.

Risks

• Future performance may not meet the targets required for the remaining PSUs to vest.
• Changes in Maroney's employment status could impact the vesting of the remaining PSUs.

Future Outlook

50% of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Executive stock transactions are common in publicly traded companies and are often tied to performance-based compensation plans. The vesting of PSUs indicates that Alignment Healthcare is meeting its performance goals, which is a positive signal for investors. However, sales to cover tax obligations are also common and do not necessarily indicate a lack of confidence in the company's future.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PSUs to align management's interests with those of shareholders.
• Vesting schedules and performance metrics vary across companies and industries, but revenue growth, profitability, and operational efficiency are common factors.
• Sales of shares to cover tax obligations are a standard practice among executives who receive equity compensation.

Stakeholder Impact

• Shareholders may view the PSU vesting as a positive sign of company performance.
• Employees may be motivated by the achievement of performance targets and the potential for future equity awards.

Next Steps

• Remaining 50% of PSUs to vest on December 31, 2025, contingent upon continued service.

Key Dates